# California Challenges Expert Witness on Abortion Pill Reversal Safety

California's deputy attorney general cross-examined a defense expert witness on the scientific validity of abortion pill reversal procedures during litigation involving two religious organizations. The attorney targeted both the witness's credentials and his interpretation of clinical studies supporting the safety and efficacy of the treatment.

The questioning centered on whether the expert possessed sufficient qualifications to render opinions on pharmaceutical safety and whether his analysis of existing research met the Daubert standard for admissibility of expert testimony. Under federal evidence rules adopted by California courts, expert witnesses must demonstrate reliable methodology and genuine expertise before courts admit their opinions.

Abortion pill reversal, also called progesterone rescue, involves administering progesterone after a person takes mifepristone, the first medication in a two-drug abortion regimen. Proponents claim the treatment can halt pregnancy if administered quickly enough. The American College of Obstetricians and Gynecologists and other major medical organizations have stated insufficient evidence supports the procedure's safety and efficacy.

The religious organizations involved in the case sought to expand access to abortion reversals, likely challenging restrictions on the treatment or seeking to require physicians to inform patients of the option. California's attorney general's office, responsible for defending state regulations and public health policies, aggressively challenged the credibility of the evidence presented.

This litigation reflects broader national conflict over abortion access following the Supreme Court's 2022 Dobbs decision, which eliminated the constitutional right to abortion. States including California have moved to protect abortion access, while other jurisdictions restrict the procedure. The admissibility of expert testimony on abortion reversal directly affects litigation outcomes, as courts cannot rely on unreliable scientific evidence to shape healthcare policy.

The cross-examination suggests California views the reversal procedure skeptically from a public health standpoint and intends to vigorously contest claims about its safety through rig